Dyne Therapeutics, Inc. Common Stock Share Price
NYSE: DYNUtilities
Live Dyne Therapeutics, Inc. Common Stock Share Price Chart
O H L
Dyne Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$17.43Low
$17.59High
Markets Today
| Previous Close | $18.06 |
|---|---|
| Open | $17.58 |
| Volume | 341,548 |
| Day's Range | $17.43 - $17.59 |
| 52W Range | NA |
| Market Cap | $3.23 B |
Historical Performance
| 1M Returns | -30.54 |
|---|---|
| 3M Returns | -8.79 |
| 6M Returns | -1.26 |
| 1Y Returns | +29.74 |
| 5Y Returns | +12.87 |
| 10Y Returns | +44.02 |
Dyne Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $3.23 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-466.13 M |
| Profit Margin | N/A |
| Market Cap | $3.23 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-466.13 M |
| Profit Margin | N/A |
Dyne Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$122.37 M | -$115.79 M | -$113.89 M | -$116.13 M | -$125.28 M | -$181.66 M |
| EBITDA | -$121.87 M | -$115.29 M | -$113.37 M | -$115.61 M | -$124.73 M | -$181.10 M |
| Interest Expense | $0 | -$94.00 K | -$2.90 M | -$3.19 M | -$4.20 M | -$4.59 M |
| Depreciation | $502.00 K | $503.00 K | $523.00 K | $521.00 K | $550.00 K | $560.00 K |
| Income Before Tax | -$115.36 M | -$110.86 M | -$108.04 M | -$111.95 M | -$120.85 M | -$178.56 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$115.36 M | -$110.86 M | -$108.04 M | -$111.95 M | -$120.85 M | -$178.56 M |
| Net Profit Margin | - | - | - | - | - | - |
Dyne Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $11.00 K | $11.00 K | $14.00 K | $16.00 K | $16.00 K | $16.00 K |
| Reserve & Surplus | -$1.07 B | -$1.18 B | -$1.28 B | -$1.40 B | -$1.52 B | -$1.70 B |
| Non-Current Liabilities | $18.22 M | $116.08 M | $115.43 M | $164.20 M | $163.65 M | $213.83 M |
| Current Liabilities | $33.88 M | $41.47 M | $59.85 M | $50.63 M | $51.25 M | $78.03 M |
| Total Liabilities | $52.10 M | $157.55 M | $175.28 M | $214.83 M | $214.90 M | $291.86 M |
| Fixed Assets | $5.75 M | $5.67 M | $23.97 M | $24.03 M | $23.68 M | $24.56 M |
| Current Assets | $689.50 M | $697.95 M | $806.26 M | $1.13 B | $1.02 B | $937.89 M |
| Total Assets | $721.07 M | $728.99 M | $867.06 M | $1.19 B | $1.08 B | $994.01 M |
Dyne Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$115.36 M | -$110.86 M | -$108.04 M | -$111.95 M | -$120.85 M | -$178.56 M |
| Operating Cash Flow | -$105.89 M | -$94.70 M | -$90.78 M | -$111.83 M | -$144.92 M | -$130.29 M |
| Investing Cash Flow | $1.46 M | $6.77 M | -$37.97 M | $982.00 K | -$2.39 M | -$4.79 M |
| Financing Cash Flow | $141.24 M | $100.77 M | $217.33 M | $430.96 M | $7.06 M | $58.11 M |
| Change in Cash | $36.81 M | $12.85 M | $88.58 M | $320.12 M | -$140.25 M | -$76.97 M |
Dyne Therapeutics, Inc. Common Stock Return Calculator
The Dyne Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,925
Invested Amount$10,000
Est. Returns$925
About Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Popular Stocks
FAQs
What is the share price of Dyne Therapeutics, Inc. Common Stock today?
Dyne Therapeutics, Inc. Common Stock (DYN) share price as of September 18, 2026 is $17.48. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Dyne Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Dyne Therapeutics, Inc. Common Stock (DYN) Share by opening an international trading account with Angel One.
How can I purchase Dyne Therapeutics, Inc. Common Stock shares in India?
Purchasing Dyne Therapeutics, Inc. Common Stock (DYN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Dyne Therapeutics, Inc. Common Stock (DYN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Dyne Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Dyne Therapeutics, Inc. Common Stock (DYN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Dyne Therapeutics, Inc. Common Stock?
The market capitalization of Dyne Therapeutics, Inc. Common Stock on September 18, 2026, is $3.23 B.
In which sector Dyne Therapeutics, Inc. Common Stock belongs?
Dyne Therapeutics, Inc. Common Stock operates in the Utilities sector, specifically in the Utilities industry.
What documents are required to invest in Dyne Therapeutics, Inc. Common Stock stocks?
In order to invest in Dyne Therapeutics, Inc. Common Stock (DYN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
